Flightpath Biosciences
Dr. Scribner is a board-certified internist with 25+ years experience in drug development as a clinical investigator, regulatory reviewer, and product life cycle consultant, including senior positions at the CDC and FDA Center for Biologic Evaluation and Research. He has served as a consultant to biotechnology companies working on everything from discovery and preclinical models through clinical trials, Data Safety Monitoring Committees and regulatory interactions in the US and Europe, including as Chief Regulatory Officer of Intarcia and in medical and regulatory positions at several BridgeBio companies.
This person is not in any offices
Flightpath Biosciences
Flightpath Biosciences uses advanced drug discovery tools to identify optimal therapeutic candidates and cutting-edge drug delivery technology to vastly improve drug targeting and safety, reduce negative impacts on the microbiome, speed the time-to-market and eliminate non-target antibiotic resistance risks.